Market Overview:
The global troponin T test kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiac diseases, technological advancements in troponin T test kits, and rising demand for point-of-care testing. However, the high cost of troponin T test kits may restrain the growth of this market during the forecast period. Based on type, the global troponin T test kit market is segmented into time-resolved immunofluorescence and chemiluminescence immunoassay. The chemiluminescence immunoassay segment is expected to grow at a higher CAGR than the time-resolved immunofluorescence segment during the forecast period. This can be attributed to technological advancements in chemiluminescence immunoassays that have led to increased accuracy and sensitivity compared with other methods such as ELISA or RIA. Based on application, hospitals are expected to account for a larger share of this market than clinics duringthe forecast period owingto their larger patient baseand greater need for accurate diagnosisand treatment decisions for patients with cardiac diseases.
Product Definition:
A troponin T test kit is a medical device that is used to measure the levels of troponin T in the blood. Troponin T is a protein that is found in the heart muscle. The levels of troponin T can be used to help diagnose heart attacks and other heart conditions.
Time-resolved Immunofluorescence:
Time-resolved immunofluorescence (TRIF) is a technique that allows the study of cell biology in real time. It provides high resolution images of cellular components and enables quantification as well as isolation of proteins, nucleic acids, or other biological molecules. TRIF has applications in many fields such as neurobiology, cardiology, oncology research & drug discovery among others.
Chemiluminescence Immunoassay:
Chemiluminescence immunoassay (CLIA) is a technique used for the detection of Troponin T (TnT) in urine and serum. It utilizes the principle of chemiluminescence reaction which is based on the interference of light and chemical reactions. The test takes around 10 to 15 minutes to complete.
Application Insights:
Clinical diagnosis of acute myocardial infarction (AMI) dominated the global troponin T test kit market in 2017. This is attributed to the rising prevalence of AMI and increasing government initiatives for early diagnosis. According to a study published in The Journal of the American Medical Association, over 1/3rd patients suffering from chest pain are found to have non-ST-segment elevation acute coronary syndrome (ACS). Therefore, it is important for cardiology laboratories to diagnose ACS with high specificity and sensitivity. Thus, growing demand for rapid diagnostic solutions that help reduce turnaround time is expectedto boost segment growth during the forecast period.
The use of biomarkers as a screening tool before invasive cardiac procedures has gained significant traction due largelyto its ability to identify patients at high riskof developing adverse events related tomicrovascular complications within 6 months after an adverse event occurs or before major surgery i.e.
Regional Analysis:
North America dominated the global troponin T test kit market in 2017. The increasing prevalence of cardiac disorders, rising geriatric population, and high adoption rate of new technologies are some factors responsible for its largest share. Moreover, the presence of well-established healthcare facilities and favorable reimbursement policies are also contributing towards its large share.
Asia Pacific is expected to witness a lucrative CAGR during the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding early diagnosis & treatment options for various diseases. Furthermore, an increase in government initiatives aimed at creating awareness about cardiovascular diseases is also anticipated to drive growth over the forecast period.
Growth Factors:
- Increasing incidence of heart diseases: The increasing incidence of heart diseases is one of the key growth drivers for the Troponin T Test Kit market. According to a study by the World Health Organization (WHO), cardiovascular diseases are responsible for around 17.3 million deaths every year, which is approximately 31% of all global deaths. This number is expected to increase in the coming years due to the rising prevalence of risk factors such as obesity, physical inactivity, and smoking. Thus, there will be an increased demand for Troponin T Test Kits in order to diagnose and treat heart diseases at an early stage.
- Technological advancements: The technological advancements in diagnostic testing are another key growth driver for the Troponin T Test Kit market. With continuous innovations taking place in this field, healthcare professionals are now able to detect cardiac biomarkers at lower concentrations with greater accuracy than ever before using point-of-care devices or laboratory-based tests kits such as Troponin T Test Kits . This is likely to result in an increased demand for these kits from hospitals and other clinical settings worldwide over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Troponin T Test Kit Market Research Report
By Type
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
By Application
Hospital, Clinic
By Companies
Easydiagnosis, Innodx
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Troponin T Test Kit Market Report Segments:
The global Troponin T Test Kit market is segmented on the basis of:
Types
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Easydiagnosis
- Innodx
Highlights of The Troponin T Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Time-resolved Immunofluorescence
- Chemiluminescence Immunoassay
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Troponin T Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Troponin T Test Kit is a laboratory tool used to measure troponin levels in the blood. Troponins are proteins that are released from cells during injury or death. Levels of troponin T can indicate the severity of a cardiac event, such as an infarction (a blockage) or heart failure.
Some of the major companies in the troponin t test kit market are Easydiagnosis, Innodx.
The troponin t test kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Troponin T Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Troponin T Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Troponin T Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Troponin T Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Troponin T Test Kit Market Size & Forecast, 2020-2028
4.5.1 Troponin T Test Kit Market Size and Y-o-Y Growth
4.5.2 Troponin T Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Time-resolved Immunofluorescence
5.2.2 Chemiluminescence Immunoassay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Troponin T Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Troponin T Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Time-resolved Immunofluorescence
9.6.2 Chemiluminescence Immunoassay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Time-resolved Immunofluorescence
10.6.2 Chemiluminescence Immunoassay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Time-resolved Immunofluorescence
11.6.2 Chemiluminescence Immunoassay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Time-resolved Immunofluorescence
12.6.2 Chemiluminescence Immunoassay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Time-resolved Immunofluorescence
13.6.2 Chemiluminescence Immunoassay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Troponin T Test Kit Market: Competitive Dashboard
14.2 Global Troponin T Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Easydiagnosis
14.3.2 Innodx
